These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1510 related items for PubMed ID: 17408912

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
    Guillevin L.
    Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment.
    Haubitz M.
    Vasa; 2007 May; 36(2):81-9. PubMed ID: 17708098
    [Abstract] [Full Text] [Related]

  • 7. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study Group.
    N Engl J Med; 2008 Dec 25; 359(26):2790-803. PubMed ID: 19109574
    [Abstract] [Full Text] [Related]

  • 8. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C.
    Rev Prat; 2008 Mar 15; 58(5):522-32. PubMed ID: 18524109
    [Abstract] [Full Text] [Related]

  • 9. Biological therapies: new treatment options for ANCA-associated vasculitis?
    Aries PM, Lamprecht P, Gross WL.
    Expert Opin Biol Ther; 2007 Apr 15; 7(4):521-33. PubMed ID: 17373903
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement.
    Roccatello D, Baldovino S, Alpa M, Rossi D, Napoli F, Naretto C, Cavallo R, Giachino O.
    Clin Exp Rheumatol; 2008 Apr 15; 26(3 Suppl 49):S67-71. PubMed ID: 18799057
    [Abstract] [Full Text] [Related]

  • 13. Primary systemic vasculitis.
    Day C, Savage C.
    Minerva Med; 2001 Oct 15; 92(5):349-63. PubMed ID: 11675579
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of systemic vasculitides].
    Guillevin L, Pagnoux C.
    Rev Prat; 2008 Mar 15; 58(5):541-4. PubMed ID: 18524111
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
    PLoS One; 2017 Mar 15; 12(10):e0185880. PubMed ID: 29016646
    [Abstract] [Full Text] [Related]

  • 16. [New aspects in ANCA-associated vasculitides].
    Lamprecht P.
    Med Klin (Munich); 2004 Sep 15; 99(9):518-22. PubMed ID: 15372181
    [Abstract] [Full Text] [Related]

  • 17. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN, Woronik V, Halpern AS, Barbas CS.
    J Bras Pneumol; 2011 Sep 15; 37(6):809-16. PubMed ID: 22241040
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun 15; 24(161):145-8. PubMed ID: 26436161
    [Abstract] [Full Text] [Related]

  • 20. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.
    Semple D, Keogh J, Forni L, Venn R.
    Crit Care; 2005 Apr 15; 9(2):193-7. PubMed ID: 15774077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.